Guys , even if Amgen made their payment in Dec. , how would a "one-off payment "made by Amgen be classified as 'Receipts from customers" as that hardly meets the definition of "revenue from regular , on-going business activities .
I lean to the $17m not including a one-off payment from Amgen ....imo .
No doubt Oslo will argue that it also includes a payment from Abbvie !!
Q
Ann: Appendix 4C - quarterly, page-48
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)